Ownership

Jack A. Khattar - President, CEO, Director at Supernus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: President, CEO, Director
Stock Symbol: SUPN on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Jack A. Khattar - trading volume in the past year for Supernus Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-250K	100%	$36.49	-$9.12M
Net	-250K	-100%		-$9.12M

Holdings reported by Jack A. Khattar for Supernus Pharmaceuticals, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	1.02M	$37.1M	$36.29	Nov 8, 2024	By the KBT Trust
Common Stock	926K	$33.6M	$36.29	Nov 8, 2024	Direct
Performance Share Unit	0	$0	$34.90	Sep 3, 2024	Direct	Common Stock
Employee Stock Option (Right to Buy)	322K			Feb 22, 2024	Direct	Common Stock
Employee Stock Option (Right to Buy)	0			Nov 8, 2024	Direct	Common Stock

Transactions reported by Jack A. Khattar for Supernus Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.